nodes	percent_of_prediction	percent_of_DWPC	metapath
Misoprostol—PTGER2—myometrium—uterine cancer	0.0217	0.0623	CbGeAlD
Misoprostol—PTGER3—myometrium—uterine cancer	0.0181	0.0518	CbGeAlD
Misoprostol—PTGER2—uterine cervix—uterine cancer	0.0169	0.0485	CbGeAlD
Misoprostol—PTGER4—epithelium—uterine cancer	0.0167	0.048	CbGeAlD
Misoprostol—PTGER4—smooth muscle tissue—uterine cancer	0.0161	0.0462	CbGeAlD
Misoprostol—PTGER2—decidua—uterine cancer	0.0161	0.0462	CbGeAlD
Misoprostol—PTGER4—decidua—uterine cancer	0.0158	0.0453	CbGeAlD
Misoprostol—PTGER4—renal system—uterine cancer	0.0155	0.0445	CbGeAlD
Misoprostol—PTGER2—endometrium—uterine cancer	0.0153	0.0438	CbGeAlD
Misoprostol—PTGER4—endometrium—uterine cancer	0.015	0.043	CbGeAlD
Misoprostol—PTGER2—mammalian vulva—uterine cancer	0.0148	0.0424	CbGeAlD
Misoprostol—PTGER2—uterus—uterine cancer	0.0141	0.0404	CbGeAlD
Misoprostol—PTGER4—uterus—uterine cancer	0.0138	0.0396	CbGeAlD
Misoprostol—PTGER3—smooth muscle tissue—uterine cancer	0.0137	0.0391	CbGeAlD
Misoprostol—PTGER3—renal system—uterine cancer	0.0132	0.0377	CbGeAlD
Misoprostol—PTGER2—female reproductive system—uterine cancer	0.0127	0.0363	CbGeAlD
Misoprostol—PTGER4—female reproductive system—uterine cancer	0.0124	0.0356	CbGeAlD
Misoprostol—PTGER3—uterus—uterine cancer	0.0117	0.0336	CbGeAlD
Misoprostol—PTGER2—female gonad—uterine cancer	0.0115	0.033	CbGeAlD
Misoprostol—PTGER2—vagina—uterine cancer	0.0115	0.0328	CbGeAlD
Misoprostol—PTGER4—female gonad—uterine cancer	0.0113	0.0324	CbGeAlD
Misoprostol—PTGER3—female reproductive system—uterine cancer	0.0105	0.0302	CbGeAlD
Misoprostol—PTGER3—female gonad—uterine cancer	0.00959	0.0275	CbGeAlD
Misoprostol—PTGER4—Prostaglandin Synthesis and Regulation—CYP11A1—uterine cancer	0.00874	0.116	CbGpPWpGaD
Misoprostol—PTGER2—lymph node—uterine cancer	0.00741	0.0212	CbGeAlD
Misoprostol—PTGER4—lymph node—uterine cancer	0.00728	0.0208	CbGeAlD
Misoprostol—PTGER2—Prostaglandin Synthesis and Regulation—CYP11A1—uterine cancer	0.00718	0.0953	CbGpPWpGaD
Misoprostol—Dinoprostone—CYP11A1—uterine cancer	0.00674	0.659	CrCbGaD
Misoprostol—PTGER3—Prostaglandin Synthesis and Regulation—CYP11A1—uterine cancer	0.00662	0.0879	CbGpPWpGaD
Misoprostol—PTGER2—Ovarian Infertility Genes—MLH1—uterine cancer	0.00662	0.0878	CbGpPWpGaD
Misoprostol—PTGER2—Ovarian Infertility Genes—PGR—uterine cancer	0.00627	0.0832	CbGpPWpGaD
Misoprostol—PTGER3—lymph node—uterine cancer	0.00616	0.0177	CbGeAlD
Misoprostol—PTGER2—Ovarian Infertility Genes—ESR2—uterine cancer	0.00552	0.0733	CbGpPWpGaD
Misoprostol—PTGER2—Ovarian Infertility Genes—CYP19A1—uterine cancer	0.00501	0.0666	CbGpPWpGaD
Misoprostol—PTGER2—Ovarian Infertility Genes—SMAD3—uterine cancer	0.0041	0.0545	CbGpPWpGaD
Misoprostol—Dinoprostone—CYP19A1—uterine cancer	0.00349	0.341	CrCbGaD
Misoprostol—PTGER2—Ovarian Infertility Genes—CDKN1B—uterine cancer	0.00228	0.0302	CbGpPWpGaD
Misoprostol—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.00133	0.00235	CcSEcCtD
Misoprostol—Cramp muscle—Etoposide—uterine cancer	0.00132	0.00234	CcSEcCtD
Misoprostol—Hypotension—Progesterone—uterine cancer	0.00132	0.00233	CcSEcCtD
Misoprostol—Breast pain—Epirubicin—uterine cancer	0.0013	0.0023	CcSEcCtD
Misoprostol—Glycosuria—Doxorubicin—uterine cancer	0.00129	0.00229	CcSEcCtD
Misoprostol—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00129	0.00228	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00128	0.00227	CcSEcCtD
Misoprostol—Rigors—Doxorubicin—uterine cancer	0.00128	0.00227	CcSEcCtD
Misoprostol—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.00226	CcSEcCtD
Misoprostol—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.00226	CcSEcCtD
Misoprostol—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.00224	CcSEcCtD
Misoprostol—Dysphagia—Etoposide—uterine cancer	0.00127	0.00224	CcSEcCtD
Misoprostol—Chills—Dactinomycin—uterine cancer	0.00126	0.00223	CcSEcCtD
Misoprostol—Dyspnoea—Progesterone—uterine cancer	0.00126	0.00222	CcSEcCtD
Misoprostol—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00222	CcSEcCtD
Misoprostol—Somnolence—Progesterone—uterine cancer	0.00125	0.00222	CcSEcCtD
Misoprostol—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.00221	CcSEcCtD
Misoprostol—Bronchospasm—Etoposide—uterine cancer	0.00125	0.00221	CcSEcCtD
Misoprostol—Dyspepsia—Progesterone—uterine cancer	0.00124	0.00219	CcSEcCtD
Misoprostol—Alopecia—Dactinomycin—uterine cancer	0.00124	0.00219	CcSEcCtD
Misoprostol—Sweating increased—Etoposide—uterine cancer	0.00123	0.00218	CcSEcCtD
Misoprostol—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.00218	CcSEcCtD
Misoprostol—Fatigue—Progesterone—uterine cancer	0.00121	0.00215	CcSEcCtD
Misoprostol—Pain—Progesterone—uterine cancer	0.00121	0.00213	CcSEcCtD
Misoprostol—Constipation—Progesterone—uterine cancer	0.00121	0.00213	CcSEcCtD
Misoprostol—Breast pain—Doxorubicin—uterine cancer	0.0012	0.00212	CcSEcCtD
Misoprostol—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.00211	CcSEcCtD
Misoprostol—Inflammation—Epirubicin—uterine cancer	0.00117	0.00207	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00206	CcSEcCtD
Misoprostol—Feeling abnormal—Progesterone—uterine cancer	0.00116	0.00205	CcSEcCtD
Misoprostol—Gastrointestinal pain—Progesterone—uterine cancer	0.00115	0.00204	CcSEcCtD
Misoprostol—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.00201	CcSEcCtD
Misoprostol—Pneumonia—Etoposide—uterine cancer	0.00114	0.00201	CcSEcCtD
Misoprostol—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.00201	CcSEcCtD
Misoprostol—Pulmonary embolism—Epirubicin—uterine cancer	0.00113	0.002	CcSEcCtD
Misoprostol—Phosphatase alkaline increased—Epirubicin—uterine cancer	0.00113	0.002	CcSEcCtD
Misoprostol—Anaemia—Dactinomycin—uterine cancer	0.00113	0.002	CcSEcCtD
Misoprostol—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00199	CcSEcCtD
Misoprostol—Acute coronary syndrome—Etoposide—uterine cancer	0.00111	0.00197	CcSEcCtD
Misoprostol—Abdominal pain—Progesterone—uterine cancer	0.00111	0.00197	CcSEcCtD
Misoprostol—Body temperature increased—Progesterone—uterine cancer	0.00111	0.00197	CcSEcCtD
Misoprostol—Myocardial infarction—Etoposide—uterine cancer	0.00111	0.00196	CcSEcCtD
Misoprostol—Neuropathy peripheral—Etoposide—uterine cancer	0.00111	0.00196	CcSEcCtD
Misoprostol—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.00195	CcSEcCtD
Misoprostol—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00193	CcSEcCtD
Misoprostol—Inflammation—Doxorubicin—uterine cancer	0.00108	0.00191	CcSEcCtD
Misoprostol—Neuropathy—Epirubicin—uterine cancer	0.00106	0.00188	CcSEcCtD
Misoprostol—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00105	0.00186	CcSEcCtD
Misoprostol—Pulmonary embolism—Doxorubicin—uterine cancer	0.00105	0.00185	CcSEcCtD
Misoprostol—Phosphatase alkaline increased—Doxorubicin—uterine cancer	0.00105	0.00185	CcSEcCtD
Misoprostol—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00185	CcSEcCtD
Misoprostol—Myalgia—Dactinomycin—uterine cancer	0.00104	0.00184	CcSEcCtD
Misoprostol—Hypersensitivity—Progesterone—uterine cancer	0.00104	0.00184	CcSEcCtD
Misoprostol—Asthenia—Progesterone—uterine cancer	0.00101	0.00179	CcSEcCtD
Misoprostol—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00101	0.00179	CcSEcCtD
Misoprostol—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00101	0.00179	CcSEcCtD
Misoprostol—Oedema—Dactinomycin—uterine cancer	0.000996	0.00176	CcSEcCtD
Misoprostol—Infection—Dactinomycin—uterine cancer	0.00099	0.00175	CcSEcCtD
Misoprostol—Abnormal vision—Epirubicin—uterine cancer	0.000988	0.00175	CcSEcCtD
Misoprostol—Neuropathy—Doxorubicin—uterine cancer	0.000984	0.00174	CcSEcCtD
Misoprostol—Thrombocytopenia—Dactinomycin—uterine cancer	0.000975	0.00173	CcSEcCtD
Misoprostol—Diarrhoea—Progesterone—uterine cancer	0.000964	0.00171	CcSEcCtD
Misoprostol—Phlebitis—Epirubicin—uterine cancer	0.000954	0.00169	CcSEcCtD
Misoprostol—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	0.000945	0.00167	CcSEcCtD
Misoprostol—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000941	0.00166	CcSEcCtD
Misoprostol—Dizziness—Progesterone—uterine cancer	0.000932	0.00165	CcSEcCtD
Misoprostol—Vascular purpura—Epirubicin—uterine cancer	0.000919	0.00163	CcSEcCtD
Misoprostol—Immune system disorder—Etoposide—uterine cancer	0.000917	0.00162	CcSEcCtD
Misoprostol—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000916	0.00162	CcSEcCtD
Misoprostol—Abnormal vision—Doxorubicin—uterine cancer	0.000914	0.00162	CcSEcCtD
Misoprostol—Chills—Etoposide—uterine cancer	0.00091	0.00161	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000907	0.00161	CcSEcCtD
Misoprostol—Alopecia—Etoposide—uterine cancer	0.000897	0.00159	CcSEcCtD
Misoprostol—Vomiting—Progesterone—uterine cancer	0.000896	0.00158	CcSEcCtD
Misoprostol—Rash—Progesterone—uterine cancer	0.000889	0.00157	CcSEcCtD
Misoprostol—Dermatitis—Progesterone—uterine cancer	0.000888	0.00157	CcSEcCtD
Misoprostol—Phlebitis—Doxorubicin—uterine cancer	0.000883	0.00156	CcSEcCtD
Misoprostol—Headache—Progesterone—uterine cancer	0.000883	0.00156	CcSEcCtD
Misoprostol—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	0.000875	0.00155	CcSEcCtD
Misoprostol—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000874	0.00155	CcSEcCtD
Misoprostol—Fatigue—Dactinomycin—uterine cancer	0.000859	0.00152	CcSEcCtD
Misoprostol—Back pain—Etoposide—uterine cancer	0.000854	0.00151	CcSEcCtD
Misoprostol—Purpura—Epirubicin—uterine cancer	0.000853	0.00151	CcSEcCtD
Misoprostol—Pain—Dactinomycin—uterine cancer	0.000852	0.00151	CcSEcCtD
Misoprostol—Vascular purpura—Doxorubicin—uterine cancer	0.00085	0.0015	CcSEcCtD
Misoprostol—Muscle spasms—Etoposide—uterine cancer	0.000849	0.0015	CcSEcCtD
Misoprostol—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000844	0.00149	CcSEcCtD
Misoprostol—Nausea—Progesterone—uterine cancer	0.000837	0.00148	CcSEcCtD
Misoprostol—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000822	0.00145	CcSEcCtD
Misoprostol—Feeling abnormal—Dactinomycin—uterine cancer	0.000821	0.00145	CcSEcCtD
Misoprostol—Anaemia—Etoposide—uterine cancer	0.000816	0.00144	CcSEcCtD
Misoprostol—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000815	0.00144	CcSEcCtD
Misoprostol—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000812	0.00144	CcSEcCtD
Misoprostol—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000805	0.00142	CcSEcCtD
Misoprostol—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000804	0.00142	CcSEcCtD
Misoprostol—Headache—Medroxyprogesterone Acetate—uterine cancer	0.0008	0.00142	CcSEcCtD
Misoprostol—Purpura—Doxorubicin—uterine cancer	0.000789	0.0014	CcSEcCtD
Misoprostol—Abdominal pain—Dactinomycin—uterine cancer	0.000787	0.00139	CcSEcCtD
Misoprostol—Body temperature increased—Dactinomycin—uterine cancer	0.000787	0.00139	CcSEcCtD
Misoprostol—Loss of consciousness—Etoposide—uterine cancer	0.000776	0.00137	CcSEcCtD
Misoprostol—Dehydration—Epirubicin—uterine cancer	0.000765	0.00135	CcSEcCtD
Misoprostol—Hypertension—Etoposide—uterine cancer	0.000763	0.00135	CcSEcCtD
Misoprostol—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000761	0.00135	CcSEcCtD
Misoprostol—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000759	0.00134	CcSEcCtD
Misoprostol—Chest pain—Etoposide—uterine cancer	0.000752	0.00133	CcSEcCtD
Misoprostol—Breast disorder—Epirubicin—uterine cancer	0.000743	0.00131	CcSEcCtD
Misoprostol—Hypersensitivity—Dactinomycin—uterine cancer	0.000734	0.0013	CcSEcCtD
Misoprostol—Confusional state—Etoposide—uterine cancer	0.000727	0.00129	CcSEcCtD
Misoprostol—Anaphylactic shock—Etoposide—uterine cancer	0.000721	0.00128	CcSEcCtD
Misoprostol—Infection—Etoposide—uterine cancer	0.000716	0.00127	CcSEcCtD
Misoprostol—Asthenia—Dactinomycin—uterine cancer	0.000715	0.00126	CcSEcCtD
Misoprostol—Dysphagia—Epirubicin—uterine cancer	0.000711	0.00126	CcSEcCtD
Misoprostol—Dehydration—Doxorubicin—uterine cancer	0.000707	0.00125	CcSEcCtD
Misoprostol—Thrombocytopenia—Etoposide—uterine cancer	0.000706	0.00125	CcSEcCtD
Misoprostol—Hyperhidrosis—Etoposide—uterine cancer	0.000697	0.00123	CcSEcCtD
Misoprostol—Breast disorder—Doxorubicin—uterine cancer	0.000687	0.00122	CcSEcCtD
Misoprostol—Bronchitis—Epirubicin—uterine cancer	0.000683	0.00121	CcSEcCtD
Misoprostol—Diarrhoea—Dactinomycin—uterine cancer	0.000682	0.00121	CcSEcCtD
Misoprostol—Hypotension—Etoposide—uterine cancer	0.000674	0.00119	CcSEcCtD
Misoprostol—Dysuria—Epirubicin—uterine cancer	0.000664	0.00118	CcSEcCtD
Misoprostol—Upper respiratory tract infection—Epirubicin—uterine cancer	0.00066	0.00117	CcSEcCtD
Misoprostol—Dysphagia—Doxorubicin—uterine cancer	0.000658	0.00116	CcSEcCtD
Misoprostol—Dyspnoea—Etoposide—uterine cancer	0.000643	0.00114	CcSEcCtD
Misoprostol—Somnolence—Etoposide—uterine cancer	0.000641	0.00113	CcSEcCtD
Misoprostol—Pneumonia—Epirubicin—uterine cancer	0.000637	0.00113	CcSEcCtD
Misoprostol—Drowsiness—Epirubicin—uterine cancer	0.000634	0.00112	CcSEcCtD
Misoprostol—Vomiting—Dactinomycin—uterine cancer	0.000633	0.00112	CcSEcCtD
Misoprostol—Bronchitis—Doxorubicin—uterine cancer	0.000632	0.00112	CcSEcCtD
Misoprostol—Rash—Dactinomycin—uterine cancer	0.000628	0.00111	CcSEcCtD
Misoprostol—Fatigue—Etoposide—uterine cancer	0.000622	0.0011	CcSEcCtD
Misoprostol—Neuropathy peripheral—Epirubicin—uterine cancer	0.000621	0.0011	CcSEcCtD
Misoprostol—Pain—Etoposide—uterine cancer	0.000616	0.00109	CcSEcCtD
Misoprostol—Constipation—Etoposide—uterine cancer	0.000616	0.00109	CcSEcCtD
Misoprostol—Urinary tract infection—Epirubicin—uterine cancer	0.000616	0.00109	CcSEcCtD
Misoprostol—Conjunctivitis—Epirubicin—uterine cancer	0.000616	0.00109	CcSEcCtD
Misoprostol—Dysuria—Doxorubicin—uterine cancer	0.000615	0.00109	CcSEcCtD
Misoprostol—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000611	0.00108	CcSEcCtD
Misoprostol—Haematuria—Epirubicin—uterine cancer	0.000604	0.00107	CcSEcCtD
Misoprostol—Epistaxis—Epirubicin—uterine cancer	0.000598	0.00106	CcSEcCtD
Misoprostol—Feeling abnormal—Etoposide—uterine cancer	0.000594	0.00105	CcSEcCtD
Misoprostol—Nausea—Dactinomycin—uterine cancer	0.000592	0.00105	CcSEcCtD
Misoprostol—Pneumonia—Doxorubicin—uterine cancer	0.00059	0.00104	CcSEcCtD
Misoprostol—Gastrointestinal pain—Etoposide—uterine cancer	0.00059	0.00104	CcSEcCtD
Misoprostol—Drowsiness—Doxorubicin—uterine cancer	0.000586	0.00104	CcSEcCtD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	0.000579	0.00769	CbGpPWpGaD
Misoprostol—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000575	0.00102	CcSEcCtD
Misoprostol—Abdominal pain—Etoposide—uterine cancer	0.00057	0.00101	CcSEcCtD
Misoprostol—Body temperature increased—Etoposide—uterine cancer	0.00057	0.00101	CcSEcCtD
Misoprostol—Urinary tract infection—Doxorubicin—uterine cancer	0.00057	0.00101	CcSEcCtD
Misoprostol—Conjunctivitis—Doxorubicin—uterine cancer	0.00057	0.00101	CcSEcCtD
Misoprostol—Haematuria—Doxorubicin—uterine cancer	0.000559	0.000989	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—AKR1B10—uterine cancer	0.000556	0.00737	CbGpPWpGaD
Misoprostol—Epistaxis—Doxorubicin—uterine cancer	0.000553	0.000978	CcSEcCtD
Misoprostol—Visual impairment—Epirubicin—uterine cancer	0.000548	0.00097	CcSEcCtD
Misoprostol—Hypersensitivity—Etoposide—uterine cancer	0.000531	0.00094	CcSEcCtD
Misoprostol—Tinnitus—Epirubicin—uterine cancer	0.00053	0.000938	CcSEcCtD
Misoprostol—Asthenia—Etoposide—uterine cancer	0.000517	0.000915	CcSEcCtD
Misoprostol—Immune system disorder—Epirubicin—uterine cancer	0.000514	0.000909	CcSEcCtD
Misoprostol—Chills—Epirubicin—uterine cancer	0.00051	0.000903	CcSEcCtD
Misoprostol—Arrhythmia—Epirubicin—uterine cancer	0.000508	0.000899	CcSEcCtD
Misoprostol—Visual impairment—Doxorubicin—uterine cancer	0.000507	0.000897	CcSEcCtD
Misoprostol—Alopecia—Epirubicin—uterine cancer	0.000503	0.000889	CcSEcCtD
Misoprostol—Diarrhoea—Etoposide—uterine cancer	0.000493	0.000872	CcSEcCtD
Misoprostol—Tinnitus—Doxorubicin—uterine cancer	0.000491	0.000868	CcSEcCtD
Misoprostol—Flatulence—Epirubicin—uterine cancer	0.000488	0.000863	CcSEcCtD
Misoprostol—Back pain—Epirubicin—uterine cancer	0.000479	0.000847	CcSEcCtD
Misoprostol—Dizziness—Etoposide—uterine cancer	0.000477	0.000843	CcSEcCtD
Misoprostol—Muscle spasms—Epirubicin—uterine cancer	0.000476	0.000842	CcSEcCtD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	0.000476	0.00631	CbGpPWpGaD
Misoprostol—Immune system disorder—Doxorubicin—uterine cancer	0.000475	0.000841	CcSEcCtD
Misoprostol—Chills—Doxorubicin—uterine cancer	0.000472	0.000835	CcSEcCtD
Misoprostol—Arrhythmia—Doxorubicin—uterine cancer	0.00047	0.000832	CcSEcCtD
Misoprostol—Alopecia—Doxorubicin—uterine cancer	0.000465	0.000823	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—RNF43—uterine cancer	0.00046	0.00611	CbGpPWpGaD
Misoprostol—Vomiting—Etoposide—uterine cancer	0.000458	0.000811	CcSEcCtD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	0.000458	0.00608	CbGpPWpGaD
Misoprostol—Anaemia—Epirubicin—uterine cancer	0.000458	0.00081	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—AKR1B10—uterine cancer	0.000456	0.00606	CbGpPWpGaD
Misoprostol—Rash—Etoposide—uterine cancer	0.000455	0.000804	CcSEcCtD
Misoprostol—Dermatitis—Etoposide—uterine cancer	0.000454	0.000803	CcSEcCtD
Misoprostol—Headache—Etoposide—uterine cancer	0.000452	0.000799	CcSEcCtD
Misoprostol—Flatulence—Doxorubicin—uterine cancer	0.000451	0.000799	CcSEcCtD
Misoprostol—Syncope—Epirubicin—uterine cancer	0.000444	0.000785	CcSEcCtD
Misoprostol—Back pain—Doxorubicin—uterine cancer	0.000443	0.000784	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—CCL2—uterine cancer	0.000441	0.00585	CbGpPWpGaD
Misoprostol—Muscle spasms—Doxorubicin—uterine cancer	0.00044	0.000779	CcSEcCtD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	0.000439	0.00583	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—CXCL8—uterine cancer	0.000437	0.00579	CbGpPWpGaD
Misoprostol—Loss of consciousness—Epirubicin—uterine cancer	0.000435	0.00077	CcSEcCtD
Misoprostol—Nausea—Etoposide—uterine cancer	0.000428	0.000757	CcSEcCtD
Misoprostol—Hypertension—Epirubicin—uterine cancer	0.000427	0.000756	CcSEcCtD
Misoprostol—Anaemia—Doxorubicin—uterine cancer	0.000423	0.000749	CcSEcCtD
Misoprostol—Arthralgia—Epirubicin—uterine cancer	0.000422	0.000746	CcSEcCtD
Misoprostol—Chest pain—Epirubicin—uterine cancer	0.000422	0.000746	CcSEcCtD
Misoprostol—Myalgia—Epirubicin—uterine cancer	0.000422	0.000746	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—INHBA—uterine cancer	0.000421	0.00559	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—AKR1B10—uterine cancer	0.000421	0.00559	CbGpPWpGaD
Misoprostol—Anxiety—Epirubicin—uterine cancer	0.00042	0.000743	CcSEcCtD
Misoprostol—Syncope—Doxorubicin—uterine cancer	0.000411	0.000727	CcSEcCtD
Misoprostol—Confusional state—Epirubicin—uterine cancer	0.000407	0.000721	CcSEcCtD
Misoprostol—Anaphylactic shock—Epirubicin—uterine cancer	0.000404	0.000715	CcSEcCtD
Misoprostol—Oedema—Epirubicin—uterine cancer	0.000404	0.000715	CcSEcCtD
Misoprostol—Loss of consciousness—Doxorubicin—uterine cancer	0.000403	0.000712	CcSEcCtD
Misoprostol—Infection—Epirubicin—uterine cancer	0.000401	0.00071	CcSEcCtD
Misoprostol—Shock—Epirubicin—uterine cancer	0.000398	0.000703	CcSEcCtD
Misoprostol—Thrombocytopenia—Epirubicin—uterine cancer	0.000396	0.0007	CcSEcCtD
Misoprostol—Hypertension—Doxorubicin—uterine cancer	0.000396	0.0007	CcSEcCtD
Misoprostol—Hyperhidrosis—Epirubicin—uterine cancer	0.000391	0.000691	CcSEcCtD
Misoprostol—Arthralgia—Doxorubicin—uterine cancer	0.00039	0.00069	CcSEcCtD
Misoprostol—Chest pain—Doxorubicin—uterine cancer	0.00039	0.00069	CcSEcCtD
Misoprostol—Myalgia—Doxorubicin—uterine cancer	0.00039	0.00069	CcSEcCtD
Misoprostol—Anxiety—Doxorubicin—uterine cancer	0.000389	0.000688	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—AKR1C1—uterine cancer	0.000379	0.00503	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—RNF43—uterine cancer	0.000378	0.00502	CbGpPWpGaD
Misoprostol—Hypotension—Epirubicin—uterine cancer	0.000378	0.000668	CcSEcCtD
Misoprostol—Confusional state—Doxorubicin—uterine cancer	0.000377	0.000667	CcSEcCtD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	0.000376	0.00499	CbGpPWpGaD
Misoprostol—Anaphylactic shock—Doxorubicin—uterine cancer	0.000374	0.000661	CcSEcCtD
Misoprostol—Oedema—Doxorubicin—uterine cancer	0.000374	0.000661	CcSEcCtD
Misoprostol—Infection—Doxorubicin—uterine cancer	0.000371	0.000657	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000368	0.000651	CcSEcCtD
Misoprostol—Shock—Doxorubicin—uterine cancer	0.000368	0.000651	CcSEcCtD
Misoprostol—Thrombocytopenia—Doxorubicin—uterine cancer	0.000366	0.000648	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—CCL2—uterine cancer	0.000362	0.00481	CbGpPWpGaD
Misoprostol—Hyperhidrosis—Doxorubicin—uterine cancer	0.000361	0.000639	CcSEcCtD
Misoprostol—Dyspnoea—Epirubicin—uterine cancer	0.00036	0.000637	CcSEcCtD
Misoprostol—Somnolence—Epirubicin—uterine cancer	0.000359	0.000635	CcSEcCtD
Misoprostol—Dyspepsia—Epirubicin—uterine cancer	0.000356	0.000629	CcSEcCtD
Misoprostol—Hypotension—Doxorubicin—uterine cancer	0.000349	0.000618	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—RNF43—uterine cancer	0.000349	0.00463	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—CXCL8—uterine cancer	0.000349	0.00463	CbGpPWpGaD
Misoprostol—Fatigue—Epirubicin—uterine cancer	0.000348	0.000616	CcSEcCtD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	0.000347	0.00461	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—INHBA—uterine cancer	0.000346	0.00459	CbGpPWpGaD
Misoprostol—Pain—Epirubicin—uterine cancer	0.000346	0.000611	CcSEcCtD
Misoprostol—Constipation—Epirubicin—uterine cancer	0.000346	0.000611	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000341	0.000603	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—CCL2—uterine cancer	0.000334	0.00444	CbGpPWpGaD
Misoprostol—Dyspnoea—Doxorubicin—uterine cancer	0.000333	0.00059	CcSEcCtD
Misoprostol—Feeling abnormal—Epirubicin—uterine cancer	0.000333	0.000589	CcSEcCtD
Misoprostol—Somnolence—Doxorubicin—uterine cancer	0.000332	0.000588	CcSEcCtD
Misoprostol—Gastrointestinal pain—Epirubicin—uterine cancer	0.00033	0.000585	CcSEcCtD
Misoprostol—Dyspepsia—Doxorubicin—uterine cancer	0.000329	0.000582	CcSEcCtD
Misoprostol—Fatigue—Doxorubicin—uterine cancer	0.000322	0.00057	CcSEcCtD
Misoprostol—Constipation—Doxorubicin—uterine cancer	0.00032	0.000566	CcSEcCtD
Misoprostol—Pain—Doxorubicin—uterine cancer	0.00032	0.000566	CcSEcCtD
Misoprostol—Body temperature increased—Epirubicin—uterine cancer	0.000319	0.000565	CcSEcCtD
Misoprostol—Abdominal pain—Epirubicin—uterine cancer	0.000319	0.000565	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—INHBA—uterine cancer	0.000319	0.00424	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—AKR1C1—uterine cancer	0.000311	0.00413	CbGpPWpGaD
Misoprostol—Feeling abnormal—Doxorubicin—uterine cancer	0.000308	0.000545	CcSEcCtD
Misoprostol—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000306	0.000541	CcSEcCtD
Misoprostol—Hypersensitivity—Epirubicin—uterine cancer	0.000298	0.000527	CcSEcCtD
Misoprostol—Abdominal pain—Doxorubicin—uterine cancer	0.000296	0.000523	CcSEcCtD
Misoprostol—Body temperature increased—Doxorubicin—uterine cancer	0.000296	0.000523	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—AKR1C3—uterine cancer	0.000292	0.00387	CbGpPWpGaD
Misoprostol—Asthenia—Epirubicin—uterine cancer	0.00029	0.000513	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—AKR1C1—uterine cancer	0.000287	0.00381	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—CXCL8—uterine cancer	0.000286	0.0038	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PGR—uterine cancer	0.000284	0.00378	CbGpPWpGaD
Misoprostol—Diarrhoea—Epirubicin—uterine cancer	0.000276	0.000489	CcSEcCtD
Misoprostol—Hypersensitivity—Doxorubicin—uterine cancer	0.000275	0.000487	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—YWHAE—uterine cancer	0.000271	0.0036	CbGpPWpGaD
Misoprostol—Asthenia—Doxorubicin—uterine cancer	0.000268	0.000475	CcSEcCtD
Misoprostol—Dizziness—Epirubicin—uterine cancer	0.000267	0.000473	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—CXCL8—uterine cancer	0.000264	0.00351	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—FBXW7—uterine cancer	0.00026	0.00345	CbGpPWpGaD
Misoprostol—Vomiting—Epirubicin—uterine cancer	0.000257	0.000454	CcSEcCtD
Misoprostol—Diarrhoea—Doxorubicin—uterine cancer	0.000256	0.000453	CcSEcCtD
Misoprostol—Rash—Epirubicin—uterine cancer	0.000255	0.000451	CcSEcCtD
Misoprostol—Dermatitis—Epirubicin—uterine cancer	0.000255	0.00045	CcSEcCtD
Misoprostol—Headache—Epirubicin—uterine cancer	0.000253	0.000448	CcSEcCtD
Misoprostol—Dizziness—Doxorubicin—uterine cancer	0.000247	0.000437	CcSEcCtD
Misoprostol—Nausea—Epirubicin—uterine cancer	0.00024	0.000425	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—AKR1C3—uterine cancer	0.00024	0.00318	CbGpPWpGaD
Misoprostol—Vomiting—Doxorubicin—uterine cancer	0.000238	0.000421	CcSEcCtD
Misoprostol—Rash—Doxorubicin—uterine cancer	0.000236	0.000417	CcSEcCtD
Misoprostol—Dermatitis—Doxorubicin—uterine cancer	0.000236	0.000417	CcSEcCtD
Misoprostol—Headache—Doxorubicin—uterine cancer	0.000234	0.000414	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—PGR—uterine cancer	0.000234	0.0031	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—STK11—uterine cancer	0.000227	0.00302	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—CCL2—uterine cancer	0.000226	0.003	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—YWHAE—uterine cancer	0.000223	0.00296	CbGpPWpGaD
Misoprostol—Nausea—Doxorubicin—uterine cancer	0.000222	0.000393	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—AKR1C3—uterine cancer	0.000221	0.00294	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PGR—uterine cancer	0.000216	0.00286	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—FBXW7—uterine cancer	0.000214	0.00284	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—SOCS3—uterine cancer	0.000213	0.00283	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—YWHAE—uterine cancer	0.000206	0.00273	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CDKN2B—uterine cancer	0.000204	0.00271	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IGF1R—uterine cancer	0.000198	0.00263	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—FBXW7—uterine cancer	0.000197	0.00262	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—CXCL8—uterine cancer	0.000197	0.00262	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—STK11—uterine cancer	0.000187	0.00248	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—SMAD3—uterine cancer	0.000186	0.00247	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CCL2—uterine cancer	0.000186	0.00247	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—CXCL8—uterine cancer	0.000179	0.00238	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—FGFR2—uterine cancer	0.000178	0.00236	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—SOCS3—uterine cancer	0.000175	0.00232	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—STK11—uterine cancer	0.000172	0.00229	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—CCL2—uterine cancer	0.000172	0.00228	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CDKN2B—uterine cancer	0.000167	0.00222	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IGF1R—uterine cancer	0.000163	0.00216	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—CXCL8—uterine cancer	0.000162	0.00215	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—SOCS3—uterine cancer	0.000161	0.00214	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CDKN2B—uterine cancer	0.000154	0.00205	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—SMAD3—uterine cancer	0.000153	0.00203	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—ESR1—uterine cancer	0.000152	0.00202	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IGF1R—uterine cancer	0.00015	0.00199	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—CXCL8—uterine cancer	0.000149	0.00198	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CXCL8—uterine cancer	0.000147	0.00195	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—FGFR2—uterine cancer	0.000146	0.00193	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—NRAS—uterine cancer	0.000144	0.00191	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—SMAD3—uterine cancer	0.000141	0.00187	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—CXCL8—uterine cancer	0.000136	0.0018	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—FGFR2—uterine cancer	0.000135	0.00179	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CCL2—uterine cancer	0.000134	0.00177	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—PIK3CA—uterine cancer	0.000125	0.00166	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ESR1—uterine cancer	0.000125	0.00166	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—KRAS—uterine cancer	0.000124	0.00164	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—NRAS—uterine cancer	0.000118	0.00156	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—ESR1—uterine cancer	0.000115	0.00153	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—PIK3CA—uterine cancer	0.000114	0.00151	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—ERBB2—uterine cancer	0.000111	0.00148	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CCL2—uterine cancer	0.00011	0.00146	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—NRAS—uterine cancer	0.000109	0.00144	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CXCL8—uterine cancer	0.000106	0.0014	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—HRAS—uterine cancer	0.000105	0.00139	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CDKN1B—uterine cancer	0.000103	0.00137	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—PIK3CA—uterine cancer	0.000103	0.00136	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—AKT1—uterine cancer	0.000102	0.00136	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—KRAS—uterine cancer	0.000101	0.00135	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CCL2—uterine cancer	0.000101	0.00135	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CTNNB1—uterine cancer	9.75e-05	0.00129	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PTEN—uterine cancer	9.51e-05	0.00126	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—PIK3CA—uterine cancer	9.47e-05	0.00126	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—KRAS—uterine cancer	9.37e-05	0.00124	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—PIK3CA—uterine cancer	9.32e-05	0.00124	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—AKT1—uterine cancer	9.27e-05	0.00123	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ERBB2—uterine cancer	9.15e-05	0.00122	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—EP300—uterine cancer	9.07e-05	0.0012	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CXCL8—uterine cancer	8.68e-05	0.00115	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—HRAS—uterine cancer	8.63e-05	0.00114	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—PIK3CA—uterine cancer	8.6e-05	0.00114	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—VEGFA—uterine cancer	8.59e-05	0.00114	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—NRAS—uterine cancer	8.48e-05	0.00113	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CDKN1B—uterine cancer	8.48e-05	0.00113	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—ERBB2—uterine cancer	8.45e-05	0.00112	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—AKT1—uterine cancer	8.39e-05	0.00111	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CXCL8—uterine cancer	8.01e-05	0.00106	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CTNNB1—uterine cancer	8.01e-05	0.00106	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—HRAS—uterine cancer	7.96e-05	0.00106	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CDKN1B—uterine cancer	7.82e-05	0.00104	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PTEN—uterine cancer	7.81e-05	0.00104	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—AKT1—uterine cancer	7.74e-05	0.00103	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—AKT1—uterine cancer	7.62e-05	0.00101	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—EP300—uterine cancer	7.45e-05	0.000988	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CTNNB1—uterine cancer	7.39e-05	0.000981	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—KRAS—uterine cancer	7.3e-05	0.000969	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PTEN—uterine cancer	7.2e-05	0.000956	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—VEGFA—uterine cancer	7.05e-05	0.000936	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—AKT1—uterine cancer	7.03e-05	0.000933	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—NRAS—uterine cancer	6.97e-05	0.000924	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—EP300—uterine cancer	6.87e-05	0.000912	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PIK3CA—uterine cancer	6.71e-05	0.00089	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—VEGFA—uterine cancer	6.51e-05	0.000864	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TP53—uterine cancer	6.49e-05	0.000861	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—NRAS—uterine cancer	6.43e-05	0.000853	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—HRAS—uterine cancer	6.2e-05	0.000824	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—KRAS—uterine cancer	5.99e-05	0.000796	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—KRAS—uterine cancer	5.53e-05	0.000734	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PIK3CA—uterine cancer	5.51e-05	0.000731	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—AKT1—uterine cancer	5.48e-05	0.000727	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TP53—uterine cancer	5.33e-05	0.000707	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—HRAS—uterine cancer	5.1e-05	0.000676	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PIK3CA—uterine cancer	5.08e-05	0.000675	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TP53—uterine cancer	4.92e-05	0.000653	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—HRAS—uterine cancer	4.7e-05	0.000624	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—AKT1—uterine cancer	4.5e-05	0.000597	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—AKT1—uterine cancer	4.15e-05	0.000551	CbGpPWpGaD
